LAMIFEN®

  • Composition
  • Release form
  • Indication
  • Reception scheme
  • Contraindications
Active substance: 1 tablet contains terbinafine hydrochloride at a dose equivalent to 250 mg terbinafine;
excipients: microcrystalline cellulose, co-povidone, polyethylene glycol (macrogol) 6000, potato starch, hypromellose (hydroxypropyl methylcellulose of 50 cP), sodium starch (type A), croscarmellose sodium, colloidal anhydrous silica, magnesium stearate.
Tablets. 7 tablets in blister 1, 2 or 4 blisters in a pack.
Fungal infections of the skin and nails caused by Trichophyton (eg T. rubrum, T. mentagrophytes, T. verrucosum , T. violaceum), Microsporum canis floccosum and Epidermophyton:
- ringworm (trichophytosis smooth skin trichophytosis crotch and Tinea feet) when localization lesion severity or prevalence determine the feasibility of oral therapy;
- onychomycosis.
The drug product is intended for oral administration. Adults appoint 1 tablet of 250 mg 1 time a day. The duration of treatment depends on the nature and severity of the disease.
Hypersensitivity to terbinafine or to any component of the drug.
Price information